BG Proximal Femur
510(k) K790274
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK790274 | Date26 Mar 1979 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- JDL
- Device Class
- Class III
- Regulation
- 21 CFR Part 888.3320
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The BG Proximal Femur is a semi-constrained metal cemented acetabular component for hip prostheses, designed to replace the femoral head and acetabulum in total hip arthroplasty. It is intended for use in orthopedic surgical procedures to restore function and alleviate pain in patients with degenerative joint disease or hip fractures.
This device is supplied as a reusable surgical implant and is regulated under FDA 510(k) clearance (K790274) as a Class III medical device. It is classified under product code JDL and adheres to regulation 888.3320, with a decision of Substantially Equivalent (SESE). The BG Proximal Femur is intended for use in sterile conditions within an operating room setting and requires proper sterilization and handling as per orthopedic implant protocols.
Other devices from Howmedica Corp.
Questions
AI-generated answers, 18 Sep 2026
What types of patients is the BG Proximal Femur designed to help, and how does it restore function?
The BG Proximal Femur is intended for patients suffering from degenerative joint disease or hip fractures, where the natural femoral head and acetabulum have been damaged. It replaces these components in total hip arthroplasty to restore mobility and alleviate chronic pain by providing a stable, semi-constrained metal acetabular implant that mimics the natural hip joint’s movement.
Is the BG Proximal Femur reusable or single-use, and how should it be handled in the operating room?
The BG Proximal Femur is designed as a reusable surgical implant, meaning it is intended for multiple uses after proper sterilization. Like all orthopedic implants, it must be handled in sterile conditions within the operating room and sterilized according to standard orthopedic implant protocols to ensure safety and prevent contamination.
What regulatory pathway was followed for FDA clearance, and what does the product code JDL indicate?
The BG Proximal Femur received FDA clearance through a 510(k) submission (K790274), classified as a Class III medical device under product code JDL, which corresponds to ‘Prosthesis, Hip, Semi-Constrained (Metal Cemented Acetabular Component).’ The clearance was granted as *Substantially Equivalent (SESE)* to a predicate device, meaning it was determined to have the same intended use and technological characteristics as a previously approved product.
Are there multiple sizes or models available for the BG Proximal Femur, and how would a surgeon select the appropriate one?
The BG Proximal Femur comes in multiple sizes and models, as indicated by the extensive list of FEI numbers (e.g., 3020282716, 3007923096) in the data. These identifiers correspond to specific implant dimensions and orientations to accommodate varying patient anatomies. Surgeons would select the appropriate size based on preoperative imaging and intraoperative assessment to ensure proper fit and function during total hip arthroplasty.